• ML133 HCl: Selective Kir2.1 Inhibition for Vascular Innovati

  2026-05-28

  This thought-leadership article explores the mechanistic and translational significance of ML133 HCl, a selective Kir2.1 potassium channel inhibitor, for researchers targeting pulmonary artery smooth muscle cell proliferation. Integrating mechanistic findings, strategic protocol guidance, and competitive landscape analysis, it positions ML133 HCl—available from APExBIO—as a pivotal tool in cardiovascular ion channel research.

• SLC25A1 Drives Cisplatin Resistance via Senescence in HNSCC

  2026-05-28

  Li et al. demonstrate that SLC25A1 upregulation in HNSCC promotes cisplatin resistance by inducing cellular senescence through H3K27 acetylation–mediated gene activation. These findings position SLC25A1 as both a predictive biomarker and a potential target for overcoming chemoresistance in head and neck cancer.

• Genotyping Kit for Target Alleles: Mechanisms, Innovations &

  2026-05-27

  Discover the science and innovations behind the Genotyping Kit for target alleles of insects, tissues, fishes and cells. This in-depth analysis explores its mechanism, unique workflow advantages, and how recent advances in barrier biology inform smarter assay choices.

• Practical Laboratory Use of Angiotensin II (Asp-Arg-Val-Tyr-

  2026-05-27

  Angiotensin II (A1042) is an established research peptide for inducing vasoconstriction, studying hypertension mechanisms, and modeling vascular smooth muscle cell hypertrophy. It is not suitable for diagnostic, clinical, or long-term storage applications. This article provides actionable guidance for laboratory workflows, protocol setup, and troubleshooting using dossier-driven data.

• Dabigatran Etexilate: Advancing Oral Anticoagulation for VTE

  2026-05-26

  The reference review details the innovation and clinical impact of dabigatran etexilate, the first oral direct thrombin inhibitor approved for venous thromboembolism (VTE) prevention and stroke risk reduction in nonvalvular atrial fibrillation (AF). By circumventing the practical and pharmacological limitations of traditional anticoagulants, dabigatran enables more predictable, accessible anticoagulation therapy, with significant implications for patient management and future research.

• Human Peptide HLTP1 Protects Liver from Ischemia-Reperfusion

  2026-05-26

  A recent study identified human liver transplantation peptide 1 (HLTP1) as a novel, endogenous hepatoprotective agent that mitigates hepatic ischemia-reperfusion injury by inhibiting JNK phosphorylation and reducing apoptosis. This finding advances therapeutic strategies in liver transplantation and demonstrates the utility of peptidomics in discovering clinically relevant peptides.

• Protein A/G Magnetic Beads: Optimizing Protein Interaction W

  2026-05-25

  Protein A/G Magnetic Beads provide unmatched specificity and efficiency for antibody purification and protein-protein interaction assays—even in challenging biological matrices. Their recombinant Protein A and Protein G domains minimize background, unlocking precision in immunoprecipitation, co-IP, and Ch-IP applications.

• TSPAN18 Shields STIM1 to Drive Bone Metastasis in Prostate C

  2026-05-25

  Zhou et al. reveal that TSPAN18 protects STIM1 from TRIM32-mediated ubiquitination, stabilizing STIM1 and promoting calcium influx crucial for bone metastasis in prostate cancer. This mechanistic insight uncovers TSPAN18 as a promising therapeutic target for metastatic disease.

• Endoglin-Driven Astrocyte Reactivity in Alzheimer’s Disease

  2026-05-24

  This study reveals that endothelium-specific endoglin (ENG), delivered via cerebrovascular endothelial extracellular vesicles (CEEVs), triggers astrocyte reactivity and neuroinflammation in Alzheimer’s disease (AD) models. The findings illuminate a novel molecular link between cerebrovascular dysfunction and neuronal decline, underscoring ENG as both a mechanistic driver and potential therapeutic target in AD pathogenesis.

• Melittin: Precision Modulation of GPCR Signaling in Cancer R

  2026-05-23

  Explore how Melittin, a potent bioactive peptide, enables advanced modulation of GPCR signaling for cancer and apoptosis research. This article uniquely bridges mechanistic insights with practical assay design, revealing how recent glioblastoma findings can inform the use of Melittin in experimental workflows.

• GPNMB-Based Multimodal Model Predicts ESCC Immunotherapy Res

  2026-05-22

  This study introduces a multimodal approach integrating circulating GPNMB levels and tumor microenvironment features to predict immunotherapy response in esophageal squamous cell carcinoma (ESCC). By elucidating mechanisms of CD8+ T cell exhaustion, the research establishes a clinically scalable framework for precision immunotherapy stratification.

• Shionone Activates Mitophagy via PINK1-Parkin to Alleviate P

  2026-05-22

  This study demonstrates that shionone, a terpenoid from Ligularia fischeri, mitigates pulmonary fibrosis by activating PINK1-Parkin-mediated mitophagy, leading to effective clearance of damaged mitochondria and reduction of oxidative stress. These findings highlight a novel mechanistic target and inform future strategies for therapeutic intervention in fibrotic lung disease.

• SM-102: Optimized mRNA Delivery Lipid for Vaccine Workflows

  2026-05-21

  SM-102, a synthetic ionizable lipid, powers reliable mRNA delivery and endosomal escape in next-generation vaccine development. Discover actionable protocols and troubleshooting strategies that make SM-102 from APExBIO the gold standard for translational mRNA research.

• Sabutoclax: Pan-Bcl-2 Inhibitor for Precision Apoptosis Indu

  2026-05-21

  Sabutoclax sets a new standard for reproducible apoptosis induction in cancer research, uniquely combining broad-spectrum Bcl-2 family inhibition with superior cell permeability. This guide unlocks experimental best practices, protocol parameters, and troubleshooting insights to help researchers leverage Sabutoclax's full translational potential.

• Clathrin-Mediated Endocytosis in Grass Carp Reovirus Entry

  2026-05-20

  Wang et al. (2018) provide direct evidence that type III grass carp reovirus (GCRV104) invades host cells via clathrin-mediated endocytosis, requiring endosomal acidification and dynamin activity. Their inhibitor analysis establishes a mechanistic framework for future antiviral interventions and comparative studies of viral entry pathways.

408 records 7/28 page Previous Next First page 上5页 678910 下5页 Last page